 |
|
|
| |
Early on-treatment HBsAg level predicts response in HBeAg-positive chronic hepatitis B patients switched from long-term entecavir to peginterferon alfa-2a (40KD)
|
| |
| |
Reported by Jules levin
APASL Liver Week 2013; 6-10 June, Singapore
Q. Ning,1 M. Han,1 Y. Sun,2 J. Jiang,3 D. Tan,4 J. Hou,5 H. Tang,6 J. Sheng,7 M. Zhao8
1Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 2Tangdu Hospital, The Fourth Military Medical University, Xi'an, China; 3The First Hospital, Fujian Medical University, Fuzhou, China; 4Xiangya Hospital, Central South University, Changsha, China; 5Nanfang Hospital, Nanfang Medical University, Guangzhou, China; 6West China Hospital, Sichuan University, Chengdu, China; 7The First Hospital, Zhejiang University, Hangzhou, China; 8Shanghai Roche Pharmaceutical Co., Ltd, Shanghai, China
|
| |
|
|
|
|
|
